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Abstract
Cuba is continuing attracting the attention of the international scientific community for some important and
unexpected achievements in applied science such as health biotechnology. They represent outcomes of the 1959
decision of Cuba to develop an advanced scientific system in order to address the most urgent problems for the
development of the country and to overcome the condition of subalternity. This ambitious objective was tackled in
a very original way, making a broad and wide-ranging recourse to every effective support and collaboration, with
Soviet  but  also  Western  scientists  and  institutions,  in  addition  to  a  peculiar  Cuban  inventiveness.  Indeed,
immediately after the revolution, Cuba developed an advanced and articulated scientific system, and achieved a
level of excellence in leading scientific fields, like biotechnology, quite independently from the Soviet Union,
which was behind in this field. 
Even  the  collapse  of  the  Soviet  Union  in  the  early  1990s,  that  could  have  put  the  achievements  of  the
Revolution at risk, posing again the threat of subalternity, under an intentionally worsened American embargo, did
not change this trend: once more Cuba addressed this challenge reconfirming the strategic choice of supporting its
most advanced and profitable scientific sectors, especially the capital-intensive and typically American field of
health biotechnologies. This strategy proved to be once again a well-chosen course of action. 
Keywords: Development versus underdevelopment, Subalternity vs. Hegemony, Socially oriented scientific
choices,  Health  care  in  Cuba,  Biotechnology  in  Cuba,  Full-cycle  research-production,  South-South
cooperation
An original approach: a twofold successful fight against subalternity
Overcoming the situation of subalternity is the scary challenge that every developing country has
to  address.  Defining  what  a  situation  of  autonomy  really  means  is  also  a  complex  problem.
Sometimes  a  developing country  achieves  such a  condition  inside  the sphere of  influence  of  a
leading power, passing in some sense from a complete lack of autonomy to a dependence from the
latter,  and  its  fortunes.  Not  infrequently  overcoming  subalternity  is  a  result  far  from  being  a
definitive achievement, as it may be illustrated by Spain after the Spanish-American war of 1898, or
Russia at the unexpected collapse of the Soviet Union
Actually, in its recent history, after the victory of the Revolution in 1959, the Caribbean island
met the challenge of overcoming subalternity in two occasions, and in both cases, in very critical
conditions  and  a  strongly  disadvantageous  international  situation,  addressed  it  in  very  original
forms. In both cases the basis of Cuba's strategy was to rely on the development, in the second case
a relaunch, of an advanced scientific system. 
The first challenge for Cuba, overcoming subalternity through scientific development
In 1959 the perspectives for a modern scientific system appeared as very remote and fanciful.
Cuba was a prevalently rural country, with scarce natural resources that were strongly controlled by
foreign interests,  and a  population  of  barely  7 million  inhabitants,  with an official  literacy  rate
between 60-76%, largely  because  of lack of  educational  access  in  rural  areas  and a  paucity of
instructors  (Kellner  1989,  61).  Actually,  the  country  had  a  fairly  good  system  of  secondary
instruction,  and of basic scientific education,  but even in the university did not include modern
scientific disciplines, such as quantum theory or genetics. As the 2010 UNESCO Science Report
recalls,
«A report by the  ad hoc Truslow Commission of the International Bank for Reconstruction and
Development, which had traveled to Cuba to study the provision of loans, stated unequivocally in
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1950 that ‘in the field of applied research and labs, there was no development at all in Cuba’ (Sáenz
and García-Capote 1989)» (Clark Arxer 2010).
Aiming unwaveringly for the development of an advanced scientific system, for a small country
in these backward conditions,  could  have appeared as  a  definitely  unrealistic  objective.  On the
contrary,  this  backwardness  was  overcome  in  such  a  surprisingly  short  period  of  a  couple  of
decades.  At  the  turn  of  the  1980s  Cuba  rivaled  the  percentage  of  university  graduates  and
physicians, and the overall level of their scientific training in many highly developed nations, and
had no equals among other underdeveloped countries (Hoffmann 2004, 166-168). 
Even more peculiar was how Cuba faced this endeavor, in very original forms, essentially with an
exceptionally open-minded attitude, resorting to supports and advice from every side (from both
Western and Soviet scientists and institutions, depending on their suitability and usefulness), and
putting in the first place in its scientific choices the social and economic priorities of the population
and  the  country.  Emblematic  examples  are  how  Cuba  addressed  disaster  management  and
mitigation, and its health situation1. In spite of the expatriation of almost one half of doctors after
the Revolution, Cuba addressed and defeated the Third World illnesses during the 1970s, and soon
reaching  a  First  World  health  profile.  On  this  basis  biotechnology  had  an  impetuous  take-off,
centered on domestic problems, soon reaching by the turn of the 1980s an international standard, all
the more impressive for this small and resourceless island in such a capital-intensive sector which is
the  quintessence  of  American  industry  and  supremacy  (Baracca  and  Franconi,  2016).  Such  an
astonishing result is acknowledged by the most influential scientific journals, like Nature, Science,
and the specialized magazines (Kaiser  1998;  Thorsteinsdóttir  et  al.  2004;  Buckley 2006;  López
Mola et al. 2007; Evenson 2007; Editorial 2009; Starr 2012; Fink et al. 2014).
«Cuba’s outstanding achievements in  health  biotechnology are  a  source of  inspiration for  the
developing world. They are all the more impressive considering that the island is a small, relatively
poor country that has suffered serious economic difficulties for more than a decade. ... Despite these
difficulties, Cuba’s strong and continued emphasis on science since shortly after the 1959 revolution
has resulted in a highly developed health biotechnology sector» (Thorsteinsdóttir et al. 2004, 19).
It is true that the country enjoyed the substantial support from the Soviet Union and the Socialist
countries. However, this is far from fully explaining Cuba's success in crucial advanced scientific
sectors. In physics, the Soviet support had undoubtedly a role that could hardly be underestimated
(Baracca, Fajer and Rodríguez 2014): Soviet physics had an outstanding international standard, and
the great majority of the Cuban physicists has studied or specialized in the Soviet Union or the
Socialist countries, where they had access to the most elitist scientific institutions. Nevertheless, as
we shall  see, since the early 1960s a considerable number of physicists  from Western countries
developed collaborations with Cuba, and has brought instrumental contributions in the advances in
some crucial fields, such as microelectronics; moreover, the number of Cuban physicists who were
educated in Italy, France or elsewhere was certainly smaller but fairly significant. But the situation
was radically different in the biological sciences. For complex historical reasons Soviet biology did
not  keep up with the  most  innovative  developments  in  genetics  and molecular  biology.  It  was
however precisely in these fields that Cuba reached the most brilliant achievements starting from the
1980s,  and  these  results  were  completely  independent  from Soviet  science  (Reid-Henry  2010;
Baracca and Franconi 2016, Chapter 5). In fact, as we shall discuss below, the training of a whole
generation of Cuban geneticists and molecular biologists  entirely depended on intensive courses
carried out by Western,  mainly Italian,  biologists  in  Cuba during the early 1970s (Baracca  and
Franconi 2016, pp. 47-50), and the successive stages and collaborations of the Cuban fellows in
some of the most advanced international laboratories.
All  these contacts  and collaborations  were rapidly integrated  in the Cuban growing scientific
system, which reached its maturity and its most brilliant achievements during the 1980s. Cuba had
overcome its situation of subalternity, acquiring a substantial scientific autonomy, which does not
1 A further recent striking example of this choise: Cuba has become the first country to earn certification by the World 
Health Organization (WHO) and United Nations officials to achieve elimination of mother-to-child transmission of HIV
and syphilis. http://who.int/mediacentre/news/releases/2015/mtct-hiv-cuba/en/#  
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mean  isolation,  let  alone  autarky,  which  is  a  nonsense  in  modern  science,  but  the  ability  of
interacting and collaborating on an equal footing with the most rated international colleagues and
laboratories.
The spectrum of subalternity arises again
The Cuban scientific system concretely proved the strength and compactness it had reached when
it  held  out  against  the  almost  sudden  and  unexpected  disappearance  of  the  Soviet  Union.
Nevertheless,  the shock was dramatic,  for the whole Cuban economy and society.  Not only the
country lost from one day to the next a basic economic support,2 but it had to abruptly pass from a
protected market to one submitted to the capitalistic rules, such as the Agreement on Trade-Related
Aspects of Intellectual Property Rights (TRIPS). As we have remarked, subalternity is not overcome
once and for all. Could Cuba resist and overcome this dramatic situation? Many observers predicted
the forthcoming downfall of the Cuban regime, as it happened for all the remaining East European
ones.  After  three  decades  Cuba  faced  again  the  challenge  of  meeting  a  renewed  danger  of
subalternity, let alone survival, in a radically changed world. But Cuba seems to defy all odds. Once
again  the country addressed the challenge  reconfirming the same recipe,  that  is  reinforcing  the
support to selected scientific sectors, primarily its biotechnology complex, as a strategic choice in
order to sustain its economy and its social achievements. Other scientific sectors, which had also
reached a high international standard, were seriously jeopardized by the critical economic situation,
but  were  not  abandoned,  and,  while  biotechnology  has  made  further  brilliant  achievement,  the
Cuban scientific system in its whole withstood the blow. 
As the already cited 2010 UNESCO Science Report states,
«By the dawn of the 21st century, Cuba was perceived as being a proficient country in terms of
scientific  capacity, despite  having  experienced  more  than  four  decades  of  a trade  embargo  and
restrictions on scientific exchanges imposed by successive US administrations … In Latin America
and the Caribbean, only Brazil and Cuba qualified as ‘proficient’» (Clark Arxer 2010).
In this paper we will briefly examine this challenging case, of how Cuba has overcome the initial
condition of subalternity choosing as a key objective an advanced scientific development, and which
were the main features of this process. Our reconstruction stops at 2014 since the re-establishment
of the relations with the United States will presumably introduce unpredictable changes.
A future of men and women of science for the new revolutionary society
The revolutionary leadership faced enormous problems of every kind, while the situation with the
near imperial power was getting out of control and the relation with the USSR was not yet working
out. All the more a rhetoric gamble could appear Fidel Castro's famous bold statement in January
1960, just one year after the victory of the Revolution:
«The future of our country has to be necessarily a future of men [and women] of science, of men
[and women] of thought because that is precisely what we are mostly sowing; what we are sowing
are opportunities for intelligence» (Castro 1960).
Who could have said that this was precisely what happened in Cuba within barely 2 or 3 decades?
Although probably in a form that not even Fidel would have imagined: on the other hand, who
could foresee the future developments of science?
«After  the  1959  revolution,  Cuba  made  it  a  priority  to  find  new  ways  to  care  for  a  poor
population; part of the solution was training doctors and researchers» (Starr 2012).
2 Indeed, the Cuban-Soviet relations had gradually deteriorated in the second half of the 1980s, particularly under 
Gorbachev, both for ideological reasons, and since the latter strongly tightened its purse strings in the last years. On the 
other side, Cuba never completely got along with the Soviet system, as we have already remarked for its scientific 
choices. Nevertheless, reliance on although Soviet support and the COMECON market had always been a sound basis 
for Cuban economy.
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The very young but learned revolutionary leadership3 had a clear view not only of the crucial role
of culture and science for the emancipation of the people and the liberation from subalternity,4 but
also of which fields owed to be developed to this end. Public healthcare became immediately a
priority of the revolutionary government. 'Che' Guevara supported a strong development of basic
science, as Minister of Industry promoted courses of mathematics for the employees of the Ministry,
and foresaw the role of electronics and automation as leading fields and “fundamental political tasks
for our country” (Pérez Rojas 2014, 282; Baracca, Fajer and Rodríguez 2014, 149). In 1961 he was
the main promoter of sending Cuban students to graduate in the Soviet Union, the first six to study
electronic engineering, then moved with his assent to follow a physics degree course (Baracca, Fajer
and Rodríguez 2014, 137).
The post-revolutionary environment was pervaded by great enthusiasm and deep ferments and
forms of participation, creativity and inventiveness. After the 1961 widespread literacy campaign,
which almost eradicated illiteracy, the government laid the foundations for a profound reform of
higher education, with free enrollment for all eligible students (Arias De Fuente 2014). At a time of
violent aggression from abroad, the 1962 Higher Education Reform Law was a crucial step, which
arose  from  a  lively  discussion  that  involved  university  professors,  outside  professionals  and
students,  and envisaged a modern university  (still  conceived on western models)  and a modern
scientific  system  in  which  teaching  was  closely  related  to  scientific  research.  Every  scientific
development since then was planned with the explicit aim of developing research programs, having
as its priorities the basic social and economic needs of the country.
A priority to physics
Concerning  scientific  development,  a  peculiar  choice  characterized  the  process  in  Cuba,
inasmuch  the  development  of  a  strong  and  multi-purpose  physics  sector  was  considered  as  a
strategic  priority,  a  sound basis  for  all  other  scientific  and technical  fields.  This  choice  proved
correct, since physics has acted as the backbone of intellectual life and has provided many other
fields with scholars, methods and scientific approaches that have been important for the further
development of other disciplines in Cuba, such as medicine, biotechnology and the nanosciences.
The Faculty of Science, which previously included three sections (Ciencias Físico-Matemáticas,
Físico-Químicas, and  Naturales) whose task was the preparation of high school teachers, in 1962
was  articulated  into  seven  Schools,  of  Mathematics,  Physics,  Chemistry,  Biological  Sciences,
Geology, Geography, and Psychology. In each of them 5-year professional degree courses were
created. The situation in the new Schools was extremely difficult, since they initially lacked both
material resources and professional staff (many teachers left the country after the Revolution).
The School of Physics coped with these problems in highly original  ways,  combining native
resourcefulness with the pursuit of all  possible kinds of support and collaboration.  The students
were actively involved in teaching activities, those in the final years of their studies being used as
“assistant  students”  to  teach  freshmen  (Baracca,  Fajer  and  Rodríguez  2014,  p.  59).  “Western”
textbooks considered most adequate for the purpose were reproduced and made freely available to
teachers  and  students  as  so-called  “Revolutionary  Editions”,  thus  circumventing  the  economic
embargo enforced by the US government.
Moreover, the Cuban Revolution had raised a lively interest and great hopes all around the world
for its original features. Cuba was destination of visits of professionals and intellectuals from all
around the world, wishing to bring their  advice,  concrete support and collaboration.  Among the
3 In 1959 Fidel Castro was 33, Ernesto ‘Che’ Guevara 31, Raul Castro 28, Camilo Cienfuegos 27.
4 José Martí (1853-1895) had been the first Latin American who clearly developed a full consciousness of the 
indissoluble tie between political independence, education and emancipation from subalternity, and had specifically 
proposed science education, the study of nature, as an instrument for individual autonomy and the promotion of social 
progress, because “to study the forces of nature and learn to control them is the most direct way of solving social 
problems” (J. Martí J. Obras completas. Havana, Edición del Centenario, Editorial Lex, 1953, I, 1076).
4
most famous one can mention Jean-Paul Sartre (Sartre 1961), Simone de Beauvoir, Leo Huberman
and Paul Sweezy (Huberman and Sweezy 1960), Charles Wright Mills (1916–1962),5 the French
Marxist economist Charles Bettelheim, and Michal Kalecki from Poland. The Cuban society and
leadership were very receptive to foreign advice at  those times,  and Cuba became a crucible of
lively contributions and experiences.
Almost  contemporaneously  to  the  arrival  of  the  first  Soviet  specialists,  quite  a  few Western
physicists visited the School of Physics since 1961 for more or less extended periods of time, even
year, and brought a vital support to give advanced courses, organize laboratories and workshops,
and foster the early research activities.
Around mid-1960 a lively debate about the choice of the fields of physics to prioritize along with
the most urgent problems of the country, involved Cuban and foreign scientists, who participated to
the  1968  Cultural  Congress  of  Havana.  While  the  favourite  “forefront”  fields  were  worldwide
nuclear and high-energy physics6, the choice in Cuba finally fell on solid-state physics, a field in
which the United States  had the leadership  and were developing an advanced industrial  sector.
Solid-state and semiconductor physics was given priority at the School of Physics of the University
of Havana (in 1967 the first  solid-state  diode was made in Cuba in collaboration with Western
visiting professors) but the other important fields were not disregarded, and other scientific centres
were created.
In 1970 a peak of graduations in physics was reached, which provided a critical mass of well
trained  physicists  that  could  feed  the  needs  of  the  growing  number  of  centres  and  scientific
disciplines.
Growth of the Cuban Scientific System
In 1962 the Cuban Academy of Science was revitalized7, and promoted the development of other
scientific branches (meteorology, geophysics, astrophysics, nuclear physics, electronics) which were
consolidated as institutes during the 1970s (Clark Arxer, 1999; Baracca, Fajer and Rodríguez, 2014,
142-145).
In  1965,  following  a  proposal  by  Fidel  Castro,  the  National  Centre  for  Scientific  Research
(CNIC) was created, as a general support structure for the growing research centres and activities,
whose main purpose was to promote and support scientific research in all areas, and to develop
post-graduate training (Pruna Goodgall, 2006, 285-288; Baracca, Fajer and Rodríguez, 2014, 158-
59). Biological sciences would come to form a dominant part of the CNIC, where most members of
the highest level scientific staff of today’s biotechnological, genetic engineering and pharmaceutical
centres have been trained (see further on). It became the generator of some of the most important
Cuban research centres  (Centre  of Neurosciences,  National  Centre  of Animal  Health,  Centre  of
Research  in  Genetics  and  Biotechnology,  Centre  of  Immunoassay).  The  CNIC  developed
collaboration with leading research institutions in the Soviet Union and the socialist countries, and
also  with the  French National  Centre  for  Scientific  Research  (CNRS),  and with  Spain  and the
United States (in the area of neurosciences). 
The basic (unsuspected) support and contributions from “Western” scientists
5 Indeed, Mills’ last work was on Cuba (Mills 1960); in it, while denouncing the United States’ ignorance of history, 
including the history of its own imperialism, he stressed that one of the challenges the Revolution would have to face 
was the lack of well-qualified people.
6 Subtle strategies for the diffusion of these scientific sectors, protecting instead the most sensitive ones for military 
applications, were implemented, mostly by the United States (Krige 2006; Baracca 2012).
7 Actually, a Royal Academy of Medical, Physical and Natural Sciences of Havana had been created in 1861 (P. M. 
Pruna Goodgall. 1994. National Science in a Colonial Context: The Royal Academy of Sciences of Havana, 1861–1898.
Isis 85(3): 412–426). After the establishment of the Republic in 1902, the adjective “Royal” was eliminated. In 1962 for 
the first time the new Academy acquired a national dimension and an effective role.
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As anticipated,  the  contribution  and support  from Soviet  scientists  and institutions  to  Cuban
science could hardly be underestimated. Much less well-known are the contributions of “Western”
scientists.  In physics their  role  was complementary,  and quantitatively  not comparable  with the
Soviets’,  but they brought pivotal  contributions in some critical  moments. In a period of active
interest in the Cuban Revolution, crucial  initiatives were proposed by the foreign scientists who
participated in the Cultural Congress of Havana, in January 1968 (Baracca, Fajer and Rodríguez
2014, 151-154). Advanced Summer Courses were organized in Cuba from 1968 to 1973, in various
disciplines.  They  had  important  consequences  in  physics,  since  the  French  specialists  brought
materials and equipment (Cernogora 2014), and gave a decisive turn to Cuban microelectronics,
with  the  change  from germanium  to  planar  silicon  technology.  Actually,  the  Cuban  physicists
succeeded in developing the new techniques in a surprisingly short lapse of time, reaching around
the mid-1970s an international level in this field, comparable with that of the main much larger
Latin American countries which had a longer scientific tradition (Vigil Santos 2014; Baracca, Fajer
and Rodríguez 2014, pp.164-168). However, the introduction of high integration microelectronics
proved how subalternity can prove hard to overcome, since it cut out all the developing countries
from this promising field into which they had ventured. As a consequence, in Cuba several activities
had to be reoriented, in particular that concerning optoelectronic sensors.
If in physics the contribution from Western scientists,  no matter how important,  was after all
subsidiary with respect to that of the Soviets, on the contrary in the fields of modern biology the
Soviet  scientists  were  seriously  behind  regarding  the  modern  developments  of  genetics  and
molecular biology, and here the role of Western scientists was decisive, although still unreported
(Baracca and Franconi 2016, p. 47-50). In fact, a crucial support to the training of Cuban scientists
came from Italian specialists. Taking part in the first 1968 Summer School, the director of the group
of molecular genetics of the International Laboratory of Genetics and Biophysics of Naples, Paolo
(“Pablo”) Amati, realized the necessity of providing a sounder base in genetics, and proposed to the
Cuban academic authorities more intensive six-month courses. Three courses were in fact held from
1971  to  1973,  involving  several  of  the  best  Italian  specialists.  These  courses  trained  the  new
generation of leading Cuban scientists that have had a fundamental role in the establishment of the
next  Cuban  biotechnology  industry.  In  subsequent  years  some  of  them  participated  in  further
training  programmes  in  Italy,  and  later  in  other  international  research  centres,  in  particular  in
France, interacting and collaborating with top scientists in the field.
The range of initiatives by Italian specialists in the field of biology was even wider (Baracca and
Franconi  2016, p.  47-50).  In 1969 an Italian  molecular  biologist,  Bruno Colombo (1936-1989),
decided to move from MIT to Cuba, to the Institute of Haematology of the William Soler Hospital,
which soon became well  known throughout  Latin  America.  He specialized  in  haematology and
haemoglobin, and spent 8 years working in Cuba, where he succeeded in being sent equipment,
reagents, documentary research, circumventing the embargo (sometimes even from the US), and
developed an instrumental collaboration that led Cuban research in the field at an international level.
He also taught in the courses organized by Amati in the section of human genetics. His colleague,
the chemist Sandro Gandini, also spent a long time working in Cuba.
Moreover  the  Italian  virologists  Giovanni  Battista  Rossi  (1935-1994) and Paola  Verani  gave
summer courses from 1970 for three years, and Sancia Gaetani gave courses on nutrition.
Stabilization and achievements of a growing advanced scientific system
Many other  institutes  and centres  were  created  in  Cuba during the  1970s,  shaping the  basic
structure of an advanced scientific system of growing complexity and integration (Baracca, Fajer
and Rodríguez 2014,  175-204).  The creation  of  efficient  scientific  structures,  the acquisition  of
essential equipment and the preparation of a critical mass of trained scientists in the basic scientific
fields,  made  the  early  successes  possible,  as  regards  microelectronics.  On  the  other  hand,  the
growing complexity of the system and the multiplication of activities required new means of central
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coordination, which replaced the previous initiatives of individual institutions or groups, although
the typical Cuban inventiveness has never ceased to play a significant role.
During the 1960s and 1970s, Cuba trained about 1.8 researchers per 1,000 inhabitants, a figure far
above the average in Latin America (0.4) and close to that of Europe (2.0) (UN 2001).
“This situation placed Cuba well outside the trend of correlation between the size of a countries’
scientific system compared with that of its economy, and subsequently these favourable conditions
permitted a new development programme to be established” (López Mola et al. 2006).
Still, in 1976, at the peak of Cuban-Soviet cooperation, Cuban scientific institutions were also
affiliated  with  forty-eight  international  scientific  organizations,  and  a  further  thirty-three
applications were being processed (MINSAP 1976: cit. in Reid-Henry 2010, 175).
The door is opened towards more noteworthy achievements
During the 1980s more ambitious goals were fixed, and remarkable results accumulated. New
research centres were established or grew out of pre-existing groups and collectives, providing them
with  greater  capabilities  for  applying  their  scientific  results,  and  existing  branches  received
additional  support.  International  collaboration  agreements  and participation  in  joint  programmes
increased. The Soviet-style planning in the economy adopted by Cuba led to centralizing in the ACC
and  in  the  Ministry  of  Higher  Education  (MES)  respectively  the  decisions  concerning  the
organization  of  research  activity  and  higher  education,  as  well  as  the  establishment  of  new
collaboration agreements. Research centres became mainly multidisciplinary. The initial choice of
promoting  the  development  of  a  strong  physics  sector  proved  its  effectiveness,  apart  from its
brilliant results, since physicists, once exceeding a critical mass, also supplied well-trained scientists
to a wide variety of institutions, in which their flexible training allowed them to switch to other
related disciplines, where they contributed to developing rigorous methods and approaches. 
Actually,  Cuban  scientists  had  familiarized  with  scientific  research  in  a  very  flexible  way.
Progress in new fields advanced initially through the (surprisingly quick) learning, adaptation and
integration of new technologies to local conditions,  but it  was soon followed by more in depth
research and the swift creation of original developments.
Challenging projects and results in physics
The multiple developments and projects in physics in the 1980s cannot be thoroughly examined
here (Baracca, Fajer and Rodríguez 2014, 180-204), so just some of the most significant ones will
be mentioned.
A challenging programme in the nuclear sector was launched, having as its cornerstone the project
to build a nuclear power plant supplied by the Soviet Union in Juraguá (Cienfuegos Province), with
the goal of reducing dependence on imported oil (Baracca, Fajer and Rodríguez 2014, 189-193).
The introduction of nuclear technologies in the country’s economy required, as is always usual,
strong centralized organization and control, besides large investments. The Cuban Commission for
Atomic Energy (CEAC) was created,  responsible for coordinating the main national  institutions
involved in nuclear research activities, and as advisor to the government. The nuclear programme
was  developed  in  close  collaboration  with  the  USSR,  the  European socialist  countries  and  the
International  Atomic  Energy  Agency  (IAEA).  The  whole  sector  was  reorganized,  and  given  a
special  and favoured place and structure.  Several institutions were created for the scientific and
technological  support  of  the  programme.  This  created  some  tensions  and  unbalance  inside  the
Cuban scientific community.
The  investment  programmes  in  physics  had  a  great  impact  also  on  the  advancement  of  the
country’s electronics projects (Baracca, Fajer and Rodríguez 2014, 183-189). 
The sudden launch in 1987 of a research programme in superconductivity deserves to be mentioned,
because  it  followed  a  very  typical  Cuban  approach  (Arés  Muzio  and  Altshuler  2014).  The
phenomenon of superconductivity, discovered by Kamerlingh Onnes in 1911 in Leiden, consists in
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the  electric  resistance  of  certain  materials  vanishing  to  zero  below  a  characteristic  critical
temperature  of  a  few degrees  above  absolute  zero  (-273  oC),  precisely  below  the  liquefaction
temperature of helium (-269 oC). No experimental research in this field had been previously carried
out in Cuba, since liquid helium was not available in the country, but only liquid nitrogen (-195,80
°C).  But  in  1986  G.  Bednorz  and  A.  Müller  discovered  a  compound  with  a  higher  critical
temperature  (-248  oC,  however  still  below  the  liquefaction  temperature  of  nitrogen).  For  this
discovery, they were awarded the Nobel Prize. Less than 6 months later, Chu and his collaborators
reached in a specific ceramic material a critical temperature above -183 °C, a temperature higher
than the liquefaction temperature of nitrogen. Laboratories worldwide were now able to reproduce
this  finding.  In  Cuba,  at  the  magnetism  laboratory  in  Havana,  Oscar  Arés  Muzio,  that  had
accumulated long experience with ceramic materials, succeeded with his collaborators in creating a
high  temperature  superconductor  barely  two  months  after  Chu’s  announcement.  Such  a  world-
standard  scientific  result,  obtained  from  no  previous  experience  in  the  specific  field,  received
widespread  coverage  in  the  national  media  and  Fidel  Castro’s  direct  interest.  The  group  was
endowed with resources for setting up a new superconductivity laboratory, which attracted many
brilliant young researchers and developed high standard research.
The appearance and surprising growth of an advanced biotechnology sector
Most visible among the transformations of the 1980s was the emergence in Cuba of a high-tech
production  sector  associated  with  biotechnology,  the  medical-pharmaceutical  industry,  and  the
health care system. The absolute originality of this process was that, on the one hand it grew in an
independent way from the Soviet Union, but on the other hand it neither followed the model of
organization nor the approach of the capital-intensive multinational big biotechnological industry
(Baracca and Franconi, 2016). Indeed,
“…biotechnology  in  Cuba  was  driven  by  public  health  demand.  … In  place  of  an  economic
imperative, therefore, were the social demands that the Cuban scientists apply to the product of their
research as soon as possible. … their model of fast science was … very much against the global trend
of the time” (Reid-Henry 2010, 18-19).
This outstanding and original outcome may even be seen, almost paradoxically, as a side effect of
US policy, since Cuba´s dependence on pharmaceuticals and health supplies from other countries
drove Castro´s decision to launch, when the field of biotechnology was still in its infancy in the
world, a series of programmes aimed at applying these new techniques to the health care sector in
order to address domestic health problems. This choice could obviously avail itself of an efficient
and widespread health system, medical schools, research institutes, and factories of pharmaceutical
and medical products.
In  that  period,  some  larger  Latin  American  countries,  with  an  older  tradition,  also  set  up
programmes for the development of biotechnology (Peritore and Galve-Peritore 1995), but it was
the small island that achieved the most amazing results, and in a surprisingly short time. Cuba had
an  adequate  number  of  trained  biologists  from  the  early  intensive  courses  of  the  1970s,  who
subsequently specialized in Italy, France and other countries.
In 1981 the  Frente  Biológico (Biological  Front)  was created,  in  order  to  coordinate  biology
centres, groups and specialists, and to ensure a connection between scientific development and the
national economy, under the supervision of the Cuban Council of State. The government’s long-term
vision in supporting a sector not likely to produce short-term returns for the investments highlights a
constant feature of Cuban biotechnology, and in fact it turned out to be a key to Cuban success in
the field of health biotechnology (Thorsteinsdóttir et al. 2004).
The initial plan consisted of the rapid acquisition of international know-how and technologies and
their translation into useful products. Around 1980 a group of Cuban physicians took an interest in
the recent application of interferon for treating cancer, an illness that took priority as a public health
issue, besides heart diseases, after endemic illnesses had been eradicated in Cuba (Cooper et al.
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2006; Health in the Americas 2012, 244)8. These physicians first visited one of the most eminent
American  oncologists,  Randolph  Lee  Clark  (1906-1994),  director  of  the  MD Anderson Cancer
Hospital in Houston, who in turn visited Cuban health facilities and met Fidel Castro, leaving him
convinced that interferon was the right drug to develop (Feinsilver 1993a; Reid-Henry 2010, 13-19).
Clark directed the Cubans to Kari Cantell in Helsinki, who had developed a technique for making
useful amounts of industry-standard interferon from human blood cells.
As Cantell himself relates in detail (Cantell 1998, 141-153), at the beginning of 1981 a group of
six Cubans, virologists, immunologists and biochemists visited Cantell's laboratory for one week in
order  to  learn  the  technique.  Once back in  Cuba,  with  Castro's  direct  interest,  a  mansion  was
converted into a laboratory, and in barely a couple of months the Cuban scientists reproduced the
process and stabilized the production of interferon. For the first time Cuba entered an industrial
sector at the very moment it  was being born globally.  Moreover,  in the same year 1981 Cuban
doctors used interferon in medical practice during a virulent epidemic of haemorrhagic dengue fever
showing again  an  open-minded  and problem-solving approach as  well  as  representing  an  early
example of the so called pharmaceutical ‘repurposing’. The close link between research and clinical
testing and application would remain a peculiar feature of the Cuban biomedical system.
The development of an advanced biotechnology industry, to increase sovereignty
The  success  in  producing  and  using  interferon  posed  the  urgent  need  to  produce  greater
quantities, and led to the decision of creating the Centre for Biological Investigation (CIB) which
was built in only six months, and was to become a part of the Western Scientific Pole of Havana, a
huge scientific complex consisting at present of 52 major integrated research, education, health, and
economic institutions devoted to the biotechnology field.  The initial  work on the purification of
interferon was complemented by a parallel project to produce it by genetic engineering, a result that
few others had obtained. The orientation towards genetic engineering was not driven in Cuba by the
logic dominant in Western industry, or by the search for cutting edge scientific results, but by the
fact that it did the job, responding to national needs. Molecular biologists were immediately sent to
the Pasteur Institute in Paris. In 1984 they succeeded in developing a whole new approach from
Cantell´s  technique,  a  second-generation,  recombinant  interferon  (Reid-Henry  2010,  46-47).
Between 1982 and 1986 the development of molecular biology and genetic engineering at the CIB
represented the first step leading to their own innovations and development of knowledge. 
“By 1986 Cuba was 'the second-largest  producer of natural human leukocyte interferon, after
Finland' … Interferon was chosen as a model to develop genetic engineering and biotechnology
techniques ….and, …. it served as a model for the development of advanced molecular biology skills
… A U.S. biotechnology industry analyst substantiated the Cuban approach when he suggested in
1990 that 'alpha interferon almost serves as a paradigm for all of these biological response modifiers
…' which are at the forefront of biotechnology research” (Feinsilver 1995, 101). 
“The quality of Cuban equipment and research facility ...  was of Japanese or West  European
level, but due to the U.S. trade embargo it was very costly ... Consequently, Cuban scientists had to
learn to produce their own restriction enzymes, make tissue cultures, establish virus collections, as
well  as  to  develop  and  manufacture  equipment  to  do  electrophoresis  and  gas  chromatography”
(Feinsilver 1995, 103).
In  1986  the  Centre  for  Genetic  Engineering  and  Biotechnology  (CIGB)  was  inaugurated,
followed by the Finlay Institute (opened in 1987) and the Centre for Molecular Immunology (CIM,
opened  in  1991).  In  the  following  years the  range  of  interests  and  activities  of  Cuban
biotechnologists  considerably  widened,  in  connection  with  the  public  health  system  and  many
protein-based  pharmaceuticals  were  produced,  including  cytokines,  monoclonal  antibodies  and
vaccines. Interestingly, about the latters, all children in Cuba are vaccinated against hepatitis B and
8 Vaccination in Cuba, begun in 1962 under the National Immunization Program (NIP,) considerably reduced the 
infectious disease burden contributing to elimination of diseases such as: poliomyelitis (1962); diphtheria (1979); 
measles (1993); pertussis (1994); and rubella (1995) (Reed et al. 2007). It is worth noting that the current vaccine 
schedule targets all Cuban children for immunization against 13 diseases with 11 vaccines, eight of which are produced 
by the country’s Scientific Pole.
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meningococcal meningitis (BC), two modern recombinant vaccines, both developed in Cuba; the
latter  is the only internationally marketed vaccine available for serogroup B meningococcus and
won the World Intellectual Property Organization's gold medal for innovation (Reid-Henry 2010,
64-66). During the years 1989-90, over 96% of Cuban population groups at risk were vaccinated,
with  the  usual  close  correlation  between  research  and clinical  testing.9 Orders  for  this  vaccine
immediately arrived from Brazil, Argentina, Colombia and other countries.
“Cuban  research  also  prioritizes  developing  affordable  vaccines  for  diseases  affecting  poor
populations, such as typhoid fever and cholera: a fundamentally needs-driven, rather than market-
driven approach. This can be contrasted with transnational pharmaceutical companies, which have
come under increasing criticism for placing market interests before global health solutions, resulting
in investment of 90% of R&D dollars worldwide in developing treatments for diseases affecting the
10% of the world’s population that can afford the results” (Evenson 2007).
The ‘full-cycle’ conception was an explicit strategy, made easier by centralized state control, as
many  commentators  have  remarked  (Elderhost  1994;  Thorsteinsdóttir  et  al.  2004;  Reid-Henry
2010). The development of a national capacity in biotechnology was seen as a strategy to increase
sovereignty  and independence  from the  transnational  companies  of  the  industrialized  countries,
especially  in the medical sector. In the 1980s Cuba was already acting in the major markets in
Eastern Europe and the former Soviet Union, attempting to promote technology transfer within the
COMECON, an alliance of countries that did not recognize Western intellectual property laws, but it
also tried to increase scientific relations with the West (Reid-Henry 2010, 55-56; de la Fuente 2001),
a strategy that proved to be useful after the unforeseen collapse of the Soviet Union.
A country of men and women of science, lifting themselves out of subalternity
Summing up, during the 1980s Cuba reached the aim of overcoming the condition of subalternity
becoming indeed “a country of men and women of science”, a reservoir of intellectual resources and
know-how both  for  socialist  and  developing  countries,  upholding  its  freedom of  action  in  the
international  arena.  The  Cuban  scientific  system  reached  its  “adult”  stage,  grew  considerably
stronger, larger, and more articulated, and acquired a substantial autonomy in its organization and
development.  In  particular,  the  biomedical  complex  became  one  of  the  main  sources  of  hard
currency for  the country.  In  the field of science autonomy is  not  autarky,  but  the  capability  of
interacting, exchanging and collaborating on an equal footing with the more developed, Eastern and
Western, countries (including even, in some relevant cases, the United States).
Cuba faces a new challenge
However, the overcoming of the condition of subalternity and the attainment of full autonomy,
even in a specific sector, is never a final result, guaranteed once and forever: not even in the case of
big and powerful countries,  as was demonstrated by the sudden and unexpected collapse of the
Soviet Union. Much less in the case of Cuba, for which the consequences were truly dramatic, and
put at risk the conquest of three decades, if not the subsistence of the regime, as many analysts
foresaw. But Cuba is still there, and keeps representing a benchmark for the fresh breeze that in the
past two decades is blowing over Latin America and the Caribbean.
How did Cuba succeed in this second challenge?
A “disaster proof” scientific system
In fact, in that terrible circumstance the Cuban scientific system demonstrated the solidity it had
reached,  substantially  resisting  the  shock.  Of  course,  the  consequences  were  serious,  scientific
activities  were  profoundly  affected.  In  physics  and  in  other  scientific  sectors  several  activities
declined, or even had to be closed down or redirected (Baracca, Fajer and Rodríguez 2014, 203-208;
9 Reid-Henry (p. 66-67) discusses an interesting comparison of the practices of research and clinical testing in the case 
of this vaccine adopted by Cuba and by Norway.
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Baracca and Franconi 2016, Chapter 5). For instance,  the project of the nuclear power plant in
Juraguá was abandoned after  the  failure  to  find  alternative  international  partners.  Experimental
activities especially encountered great difficulties due to the shortage of spare parts for equipment of
Soviet fabrication. For its part, the United States tightened the economic blockade with even more
restrictive laws (Torricelli Act, 1992, and Helms-Burton Act, 1996)10. Such a stranglehold on Cuba’s
economy  worsened  shortages  of  food  and medicine  (Kirkpatrick  1996).  Irreplaceable  scientific
information and updating had to be cut, due to the prohibitive subscription fees of international
journals.
But the Cuban scientific system did not collapse, demonstrating the toughness, cohesion and level
of self-sufficiency it had reached. In this critical circumstance the ability of Cuban scientists (not to
say of Cubans in general) to make a virtue of necessity and to exploit their own resourcefulness
proved once more successful.
The  widespread  international  collaboration  established  by  the  Cuban  scientific  community
throughout the previous decades proved all the more useful in the new situation, since it provided
alternative options and invaluable opportunities (see Baracca, Renn and Wendt 2014, Part Three;
Baracca and Franconi 2016, Chapter 5). The physicists intensified their relations and exchanges
with  Spain,  Mexico,  Brazil  and other  countries,  besides  those  with  the  International  Centre  of
Theoretical Physics in Trieste.
Support to advanced science proves to be once again the trump card
Once again the renewed challenge was met by relying on science as a driving force of economic
recovery and reaffirmation of the autonomy and independence of the country. In order to keep the
Cuban economy and the Revolution afloat  Castro chose to prioritize three economic sectors for
investments: tourism, food production, and biotechnology and medical exports.
“Faced with economic calamity, Castro did something remarkable: he poured hundreds of millions
of dollars into pharmaceuticals” (Starr 2012).
Although  the  difficult  economic  situation  made  it  impossible  to  provide  equal,  or  even
comparable, support to all scientific branches.
Obviously the situation was radically different from three decades before, both domestically and
internationally. Even the most favourable analysts wondered if this choice would prove successful:
“Can biotechnology save the revolution?” (Feinsilver 1993b). Could Cuba find sufficient markets
and  ways  to  commercialize  its  products  in  the  globalized  capitalistic  market,  controlled  by
transnational pharmaceutical companies with patents, the control of markets, and enormous capital
and finances? Intellectual property (IP) rights were one more obstacle. The Cuban economy had
adapted  to  guaranteed  and  protected  markets  for  standardized  products,  lacking  the  level  of
efficiency and competitiveness of capitalist markets, with their specific commodity-related rules of
marketable quality.
Once more, and in very critical conditions, Cuba found itself on the border of the continually
growing technical gap between the poor and the rich countries, between subalternity and hegemony.
And once  more  the  Cuban government’s  courageous  choice  seems  to  have  been  a  trump card
(Baracca and Franconi 2016, Chapter 5).
Activities in the biomedical field were confirmed and even reinforced. From 1990 to 1996, the
Cuban government invested around 1 billion US dollars in the Western Havana Bio-Cluster, the
foremost Cuban biomedical complex.
“According  to  Elena  Siméon,  the  director  of  the  Academía  de  Ciencias  de  Cuba  (ACC),
approximately 8,000 people worked in scientific research relating to biotechnology in 200 research
10 The deeply controversial Helms-Burton Act extended the prohibition of trade with Cuba to companies doing business
with it and to companies that use property Cuba had nationalized in 1960 from American companies. The US 
Government prosecuted Merck, the largest pharmaceutical firm in the USA, for an exchange of scientific information 
with Cuba.
11
institutes in 1993. In the period 1988-1992, more than US $300 million was invested in medical and
pharmaceutical industrial biotechnology” (Elderhost 1994).
Addressing new challenges
With open-mindedness and creativity Cuba addressed the complex problems of a completely new
nature posed by the forced shift from the socialist to the capitalistic market. Besides the regulation
and standardization of products, the main obstacle  was represented by intellectual  property (IP)
rights. Cuba's previous form of socialist regulation of IP was the expression of public rather than
private interests (intellectual property to the author, vs. commercial property to the state). In 1986
Cuba had strongly opposed the new global  IP rights  regime in the Uruguay Round of  General
Agreement on Tariffs and Trade (GATT). The developing countries resisted accepting the TRIPS
agreement. Now Cuba had no choice but to integrate into the capitalistic system of IP, and in 1995
signed on to TRIPS (Sanchelima 2002; Càrdenas 2009; Plahte and Reid-Henry 2013). But once
again it was true to itself, integrating into the international system while keeping margins of typical
Cuban flexibility, resorting to loopholes in the embargo, and negotiating bilateral agreements with
specific countries when possible. In particular, it found an original solution to IP in state ownership.
“The patents of the Cuban industry are owned by the government agency, which avoids the
problem of mutual blocking. This agency functions as a kind of patent pool, where every firm
has the possibility  of  using complementary knowledge in  advancing new products.  … This
resembles more an internal open source of innovation [coherent with] the notion of cooperation
instead of competition” (Càrdenas 2009).
Cuba beyond the obstacles
Almost a decade later, one study concludes that
“Ten of these institutions [of the Western Havana Bio-Cluster] are at the core of the system as
they supply economic support to the whole effort with their production capacities and exports. They
are performing more than 100 research projects which have generated a product pipeline of more
than 60 new products  most  of  which are  protected by intellectual  property,  and more than 500
patents have been filed overseas” (López Mola et al. 2006).
The  Economist  Intelligence  Unit  estimated  that  the  increase  in  non-tourism services  exports
between 2003 and 2005 was around US $1.2 billion for a total of US $2.4 billion, which put non-
tourism services ahead of gross tourism earnings (of US$2.3 billion) in 2005. Most of these were
medical services (Feinsilver 2006). And a report of the Word Bank states,
“[...] the growth of the local pharmaceutical industry, which by the mid-1990s was bringing Cuba
some 100 million dollars  a  year  in  export  earnings,  has  not  only covered  domestic  demand for
medicines, but has also led to the development of products that compete on the international market.
Cuba is the only country in the world, for example, that has come up with an effective vaccine
against meningitis B” (Kaplan and Laing 2005).
The differentiation of Cuban biomedical products for the international market grew:
“the meningitis B vaccine ... was the first of its kind in the world ... A more recent example of
success is the world’s first human vaccine with a synthetic antigen for Haemophilus influenzae type
b  (Hib).  ...  Ongoing  work  includes  research  on  recombinant  Dengue  vaccine,  preventative  and
therapeutic AIDS vaccines, cholera vaccine and a cancer therapeutic vaccine11. The sector has also
successfully produced diagnostic tests and therapeutics ... In addition, Cuba is developing natural
products based on the island’s flora. …researchers in Cuba have filed about 500 patent applications
in the health  biotechnology sector  based on more than 200 inventions filed in  several  countries
throughout the world, including the United States, Europe, Brazil, India, China and South Korea.
Cuba exports biotechnology products to more than 50 countries” (Thorsteinsdóttir et al. 2004).
In the end,
11 An update of novel therapeutics and vaccines that are currently being evaluated in Cuba in clinical trials or that are in
the market was done at the ‘First International Convention IMMUNOPHARMACOLOGY-VACCIPHARMA 2015 (III
Int. Congress on Immunopharmacology + III International Congress on Pharmacology of Vaccines), Varadero, Cuba,
June 14-19, 2015. http://www.immunovaccipharmacuba.com
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“in the wake of the Soviet collapse, Cuba got so good at making knock-off drugs that a thriving
industry took hold. Today the country is the largest medicine exporter in Latin America and has more
than 50 nations on its client list. Cuban meds cost far less than their first-world counterparts, and
Fidel Castro's government has helped China, Malaysia, India, and Iran set up their own factories:
‘south-to-south technology transfer’” (Starr, 2012).
A peculiar industrial structure, “an aberration in today's world”
In evaluating  these outcomes of the Cuban biomedical  sector  in  the highly concentrated  and
competitive globalized market, one must always take into account the peculiar structure of Cuban
industry (Baracca and Franconi, 2016, Chapter 5).
“Dr Rolando Pérez, one of the top scientists at CIM-Centre of Immunology, points out that the
Cuban  biotechnology  model  is  'completely  different'  from  the  development  of  Western
pharmaceutical products. 'Pure scientific research, innovation and product development, production
and marketing are all integrated under the same roof, or at least in the same institution.' … In a
country where there are no private hospitals, and all pharmaceuticals are publicly owned, inevitably
all investment comes from the state. … Orthodox Western economists would tend to dismiss this
socialist model of medical innovation and production as a quaint aberration in today's world, clearly
out of synch in the globalized economy. But the Cuban record boasts 26 inventions with more than
100 international patents already granted” (Fawthrop 2004).
Concerning the Cuban scientific system on the whole, such a targeted effort in the biomedical
sector in that difficult economic situation could do nothing other than make imbalances between
different scientific sectors grow.
“During the Special Period, the universities suffered more cutbacks than the research institutions
in the health biotechnology sector, and some university centres struggled to do research. Research
collaboration between the universities and the research institutions has been encouraged, and some
university institutions have made impressive contributions to health biotechnology. For example,
researchers from the Faculty of Chemistry at the University of Havana made a leading contribution
in  the  development  of  the  synthetic  H.  influenzae type  b  vaccine.  Universities  and  research
institutions also collaborate in the research training of students” (Thorsteinsdóttir et al. 2004).
Even a rather critical report that describes the crude reality of the situation in 2003, insisting in
particular on existing contradictions (Giles 2003), had to recognize that:
“Given  the  hardships  suffered  by  researchers  outside  the  charmed  circle  of  priority  applied
research projects, it is surprising not to hear more complaints from Cuban researchers. Government
control may be one factor; open dissent is a risky policy in a non-democratic country. But equally
important is an awareness that Cuba has battled against the odds to avoid the chaos and privations
suffered by neighbouring countries such as Haiti. Older Cuban scientists, who remember the right-
wing dictatorship that preceded Castro, are especially proud of what´s been achieved” (Giles 2003).
On the  other  hand,  the  burden  constituted  in  this  difficult  situation  by  the  anachronistic  US
embargo could hardly be over-emphasized.
“The US trade embargo has limited the economic options for Cuba, including development of the
health  biotechnology  sector.  For  example,  Cuba  is  forced  to  import  research  equipment  from
countries other than the United States—a situation that not only consumes time but adds to the cost.
Another challenge imposed by the poor Cuba-US relations is the increasing difficulty that Cuban
scientists  face obtaining visas to  enter  the United States to  attend conferences and other related
activities. Also, …..the uncertainties of the embargo have made it difficult for Cuban papers to be
accepted  in  US  journals.  The  embargo  therefore  restricts  the  knowledge  flow  involving  Cuban
scientists in the international scientific community and adds costs, because Cubans have to attend
conferences  that  are  held  in  countries  other  than  the  United  States.  Another  challenge  is  the
dominance of US firms in the global health biotechnology sector. This may limit the options for
Cuba  in  developing  joint  ventures,  strategic  alliances  and  licensing  of  their  technologies”
(Thorsteinsdóttir et al. 2004). 
Until a recent past, Cuba's success proved troublesome for the United States, as it emerged from
some controversial reciprocal allegations, of a political nature, of biological warfare. In 2002 John
R.  Bolton,  under-Secretary  of  State  for  arms  control  in  the  Bush  Jr.  Administration,  caused  a
13
sensation accusing Cuba of producing small quantities of germs that could be used in biological
warfare.12 The CIA itself later rebuffed these claims.13
Conclusion 
The striking  Cuban achievements  in  science  defy  the  relentless  embargo,  and even stun  and
humiliate the nearby powerful and proud enemy. No less politically unwelcome is the well-known
Cuban international  engagement  and “medical  diplomacy”.  Cuba does not miss in fact  a  single
opportunity to offer and supply medical support and disaster relief assistance, including
“an offer  to  send over  1000 doctors  as  well  as  medical  supplies  to  the  United  States  in  the
immediate aftermath of Hurricane Katrina. Although the Bush administration chose not to accept the
offer, the symbolism of this offer of help by a small, developing country that has suffered forty-five
years of US hostilities, including an economic embargo, is quite important” (Feinsilver 2006). 
As the  two foreign  secretaries  of  the  Cuban and the  US Academies  of  Science  have  jointly
remarked in Science,
“Cuba is scientifically proficient in disaster management and mitigation, vaccine production, and
epidemiology. Cuban scientists could benefit from access to research facilities that are beyond the
capabilities of any developing country, and the U.S. scientific community could benefit from high-
quality science being done in Cuba. For example, Cuba typically sits in the path of hurricanes bound
for the U.S. mainland that create great destruction, as was the case with Hurricane Katrina and again
last  month  with  Hurricane  Ike.  Cuban  scientists  and  engineers  have  learned  how  to  protect
threatened populations and minimize damage. (Jorge-Pastrana and Clegg, 2008).
Recently, in May 2015, a team of medical specialists was sent to Nepal after the fatal earthquake
while, last year, Cuba sent 256 doctors to West Africa (Liberia) where the Ebola outbreak was the
most  severe.  The doctors  returned to  Cuba in  March  2015,  after  spending  six  months  treating
patients affected by the deadly virus. The New York Times reported:
“Cuba stands to play the most robust role among the nations seeking to contain the virus [ebola].
… only Cuba and a few nongovernmental organizations are offering what is most needed: medical
professionals in the field.”14 
The recent re-establishment of diplomatic relations between US and Cuba (initiated at the end of
2014 followed by re-opening of embassies in both countries in July 2015) together with the removal
of Cuba from the terrorist list (April 2015) and removal of travel restrictions, now gives the hope
that more than 5 decades of policy hostility and subversion will be replaced by a new a policy of
engagement and cooperation. While the embargo is still there, President Obama's visit to Havana in
March 2016 will remain one of the historical dates of the 21st century.  Hopefully, all these recent
events,  in  the  near  future,  will  open  doors  for  reciprocal  (and  global)  scientific  and  medical
advances and broaden the acknowledgment of Cuban innovation in healthcare, including the lesson
of ‘how to do more with less’.  
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